Journal articles on the topic '305.5/67/092 b'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic '305.5/67/092 b.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Ferrari, Anna C., Yu-Hui Chen, Gary R. Hudes, Michael Anthony Carducci, Emmanuel S. Antonarakis, Noah M. Hahn, Yu-Ning Wong, and Robert S. DiPaola. "E2809: Androgen receptor (AR) modulation by bicalutamide (Bic) and MK-2206 (MK) in men with rising PSA at high-risk of progression after local prostate cancer (PC) treatment." Journal of Clinical Oncology 34, no. 2_suppl (January 10, 2016): 9. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.9.
Full textRomero, Samuel, Juan Montoro, Jaime Sanz, Marta Guinot, Empar Mayordomo, Rafael López, Isabel Beneyto, et al. "Comparative Study of Post-Transplant Lymphoproliferative Disorders after Solid Organ Transplantation Versus Hematopoietic Stem Cell Transplantation." Blood 126, no. 23 (December 3, 2015): 4358. http://dx.doi.org/10.1182/blood.v126.23.4358.4358.
Full textYan, Xiao J., Daniel Kalenscher, Erin Boyle, Sophia Yancopoulos, Rajendra N. Damle, Aarti Damle, Houman Khalili, et al. "Gene Set Enrichment Analysis of Ki-67high CLL Clones Suggests Complex Interactions of B-Cell Receptor Signaling and Normal Cell Interactions in the Disease." Blood 118, no. 21 (November 18, 2011): 2833. http://dx.doi.org/10.1182/blood.v118.21.2833.2833.
Full textAmisha, Fnu, Sunilkumar Kakadia, and Akash Mukherjee. "Clinical Outcome of Refractory Lymphoma Patients with Non Response to Chimeric Antigen Receptor T Cell Therapy." Blood 138, Supplement 1 (November 5, 2021): 4823. http://dx.doi.org/10.1182/blood-2021-154356.
Full textZahid, Anza, Prema P. Peethambaram, Carrie A. Thompson, Minetta C. Liu, Kathryn Jean Ruddy, Sushil s. Luis, Malcolm s. Anastasius, et al. "Descriptive evaluation of frequent patient referrals to our cardio-oncology clinic: The Mayo experience." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e14018-e14018. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14018.
Full textDavids, Matthew Steven, Andrew Warwick Roberts, John Francis Seymour, William G. Wierda, Soham D. Puvvada, Lori A. Gressick, Debbie Alter, et al. "Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL)." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e19041-e19041. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e19041.
Full textMoccia, Moccia A., Jane Donaldson, Mukesh Chhanabhai, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, et al. "The International Prognostic Factor Project Score (IPS) in Advanced Stage Hodgkin Lymphoma Has Limited Utility in Patients Treated in the Modern Era." Blood 114, no. 22 (November 20, 2009): 1554. http://dx.doi.org/10.1182/blood.v114.22.1554.1554.
Full textIssa, Ghayas C., Hagop M. Kantarjian, C. Cameron Yin, Koji Sasaki, Guillermo Garcia-Manero, Courtney DiNardo, Koichi Takahashi, et al. "Prognostic Implications of Pre-Treatment Hypodiploidy and Complex Cytogenetics in Adult Patients with Acute Lymphocytic Leukemia (ALL) Treated with Hyper-CVAD." Blood 126, no. 23 (December 3, 2015): 4874. http://dx.doi.org/10.1182/blood.v126.23.4874.4874.
Full textRabaglio, Manuela, Daniel Dietrich, Bernhard Scheibe, Thomas Ruhstaller, Franco Nole, Serenella Eppenberger, Christian Oehlschlegel, et al. "Abstract P4-01-25: Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer." Cancer Research 83, no. 5_Supplement (March 1, 2023): P4–01–25—P4–01–25. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-01-25.
Full textКвітіньйо Макарена Мартінез, Соріано Федеріко Ґонзало, Яйченко Вірджинія, Стіб Бренда, and Барейро Хуан Пабло. "Predictors of Picture Naming and Picture Categorization in Spanish." East European Journal of Psycholinguistics 6, no. 1 (June 30, 2019): 6–18. http://dx.doi.org/10.29038/eejpl.2019.6.1.cui.
Full textLykova, Inna, Ralph Rowe, Glenn Poirier, Henrik Friis, and Kate Helwig. "Mckelveyite group minerals – Part 2: Alicewilsonite-(YCe), Na2Sr2YCe(CO3)6 ⋅ 3H2O, a new species." European Journal of Mineralogy 35, no. 1 (February 28, 2023): 143–55. http://dx.doi.org/10.5194/ejm-35-143-2023.
Full textVarettoni, Marzia, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso, et al. "Prevalence and Clinical Significance of the MYD88 (L265P) Somatic Mutation in Patients with Waldenström Macroglobulinemia, IgM-Monoclonal Gammopathy of Undetermined Significance or Other Mature B-Cell Neoplasms." Blood 120, no. 21 (November 16, 2012): 2667. http://dx.doi.org/10.1182/blood.v120.21.2667.2667.
Full textCastillo, Jorge, Brady Beltran, Jaime Collins, Jose L. Diez-Martin, Francisco Hernandez-Ilizaliturri, Steven M. Horwitz, and Julie M. Vose. "Clinicopathologic Characteristics of HIV-Associated Peripheral T-Cell Lymphoma." Blood 114, no. 22 (November 20, 2009): 3924. http://dx.doi.org/10.1182/blood.v114.22.3924.3924.
Full textYilmaz, Musa, Hagop M. Kantarjian, Jorge Cortes, Guillermo Garcia-Manero, Jad Chahoud, Farhad Ravandi, Koji Sasaki, et al. "Results of Intensive Chemotherapy in 434 Adult Patients (pts) with Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL): Predictive Prognostic Model for Survival." Blood 126, no. 23 (December 3, 2015): 3722. http://dx.doi.org/10.1182/blood.v126.23.3722.3722.
Full textScheid, Christof, Pieter Sonneveld, Ingo Schmidt-Wolf, Bronno van der Holt, Thomas Hielscher, Laila el Jarari, Uta Bertsch, et al. "Influence of Renal Function on Outcome of VAD or Bortezomib, Doxorubicin, Dexamethasone (PAD) Induction Treatment Followed by High-Dose Melphalan (HDM): A Subgroup Analysis From the HOVON-65/GMMG-HD4 Randomized Phase III Trial for Newly Diagnosed Multiple Myeloma." Blood 116, no. 21 (November 19, 2010): 2396. http://dx.doi.org/10.1182/blood.v116.21.2396.2396.
Full textSchönland, Stefan, Ute Hegenbart, Christoph Kimmich, Katarina Lisenko, Dirk Hose, Hartmut Goldschmidt, Anna Jauch, Anthony D. Ho, and Michael Hundemer. "Detection and Characterization of Plasma Cell and B Cell Clones in Patients with Systemic Light Chain Amyloidosis Using Flow Cytometry." Blood 124, no. 21 (December 6, 2014): 2068. http://dx.doi.org/10.1182/blood.v124.21.2068.2068.
Full textSaxton, Claire, Kirstin Fearnley, Maria B. Gonzalo, and Cynthia Schwartz. "Abstract P3-17-01: Metastatic breast cancer caregiver participation in a psychoeducational cancer support program: Results from the frankly speaking about cancer: Metastatic breast cancer evidence-based educational workshops." Cancer Research 82, no. 4_Supplement (February 15, 2022): P3–17–01—P3–17–01. http://dx.doi.org/10.1158/1538-7445.sabcs21-p3-17-01.
Full textAndreica, I., I. Roman, X. Baraliakos, U. Kiltz, and J. Braun. "AB1188 SARS-CoV-2 VACCINATION WILLINGNESS AND PREDICTORS IN PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES (CIRD) AND WITHOUT CIRD." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1709.1–1709. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5261.
Full textSeymour, John F., Chan Yoon Cheah, Ricardo Parrondo, Meghan C. Thompson, Don A. Stevens, Masa Lasica, Michael L. Wang, et al. "First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies (BGB-16673-101)." Blood 142, Supplement 1 (November 28, 2023): 4401. http://dx.doi.org/10.1182/blood-2023-180109.
Full textCall, Justin, Muralidhar Beeram, Alexander I. Spira, Mark Bray, Dih-Yih Chen, Long Kwei, Emily Roberts-Thomson, Trisha Denny, Roger Sidhu, and Robert Wesolowski. "Abstract PO2-04-13: TWT-203: PHASE 1b/2 STUDY OF CFI-402257 AS MONOTHERAPY IN ADVANCED SOLID TUMORS AND IN COMBINATION WITH FULVESTRANT IN PATIENTS WITH ER+/HER2- ADVANCED BREAST CANCER AFTER PROGRESSION ON PRIOR CDK4/6 INHIBITORS AND ENDOCRINE THERAPY." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO2–04–13—PO2–04–13. http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-04-13.
Full textBaliakas, Panagiotis, Theodoros Moysiadis, Anastasia Hadzidimitriou, Aliki Xochelli, Mattias Mattsson, Lesley-Ann Sutton, Eva Minga, et al. "Tailored Approaches for Refined Prognostication in Chronic Lymphocytic Leukemia Patients with Mutated Versus Unmutated Immunoglobulin Receptors." Blood 128, no. 22 (December 2, 2016): 3199. http://dx.doi.org/10.1182/blood.v128.22.3199.3199.
Full textGeorge III, Qiuhong Zhao, Timothy Voorhees, Nathan Denlinger, Narendranath Epperla, Audrey M. Sigmund, Gabriela Sanchez-Petitto, et al. "Association between post-CART terminal complement complex (TCC) levels and clinically significant immune effector cell–associated neurotoxicity syndrome (ICANS)." Journal of Clinical Oncology 42, no. 16_suppl (June 1, 2024): 7036. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.7036.
Full textFarooq, Umar, Matthew J. Maurer, Stephen M. Ansell, Tasha Lin, Grzegorz S. Nowakowski, Luis Porrata, David J. Inwards, et al. "Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy." Blood 126, no. 23 (December 3, 2015): 2683. http://dx.doi.org/10.1182/blood.v126.23.2683.2683.
Full textRetiere, Christelle, Catherine Willem, Thierry Guillaume, Henri Vié, Laetitia Gautrot-Rolland, Emmanuel Scotet, Xavier Saulquin, et al. "Post-Transplant Cyclophosphamide (PTCY) Vs Anti-Thymoglobulin (ATG) As Part of the Gvhd Prophylaxis for Fludarabine/Clofarabine/Busulfan Reduced Intensity Conditioning (RIC) in Allogeneic Stem Cell Transplantation (allo-SCT): Influence on Early Immune Reconstitution." Blood 126, no. 23 (December 3, 2015): 1955. http://dx.doi.org/10.1182/blood.v126.23.1955.1955.
Full textSong, Alexander, Ron Ng, John Heller, Robin Petro, Ralph D’Agostino, Thomas Lycan, and Mercedes Porosnicu. "251 Factors evaluated as predictors of exceptional response to PD-1 inhibitors in patients with head and neck squamous cell cancer." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A272. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0251.
Full textSwic, Sebastian J., Alexander G. T. MacPhail, Chinmay B. Dalal, Steven J. T. Huang, Alina S. Gerrie, Thomas J. Nevill, Heather J. Sutherland, et al. "Prognostic Factors and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Vs. Non-Transplant Chronic Lymphocytic Leukemia (CLL) Patients: A Comparative Analysis with the Leukemia/BMT Program of British Columbia (BC) and the BC Provincial CLL Database." Blood 124, no. 21 (December 6, 2014): 2549. http://dx.doi.org/10.1182/blood.v124.21.2549.2549.
Full textDonato, Eva Ma, Rafa Andreu, Aurelio Lopez, Ana Vicente, Ana Carral, Isidro Jarque, M. Angeles Ruiz, et al. "A Retrospective Population-Based Study of a Series of 307 Treatment-naïve Patients with Chronic Lymphocytic Leukemia (CLL): Study of the Clinical Features and Efficacy of First-Line Therapy." Blood 116, no. 21 (November 19, 2010): 2452. http://dx.doi.org/10.1182/blood.v116.21.2452.2452.
Full textAljawai, Yosra, Serena McDiarmid, Joseph Cappuccio, Federico Campigotto, Steven Peter Treon, Edie A. Weller, Brenda M. Birmann, and Irene M. Ghobrial. "A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia." Blood 122, no. 21 (November 15, 2013): 1713. http://dx.doi.org/10.1182/blood.v122.21.1713.1713.
Full textMurillo, Ilda, Marcio M. Andrade, Anel Montes, Jose M. Grasa, and Pilar Giraldo. "Are IgM Hevylite® Immunoglobulin Heavy Chain/Light Chain Analysis a Useful Tool to Differentiate IgM MGUS From Waldenström Macroglobulinemia?" Blood 120, no. 21 (November 16, 2012): 5097. http://dx.doi.org/10.1182/blood.v120.21.5097.5097.
Full textNarayanan, Bhagavathi A., Cronstein Bruce, Mediero Aranzazu,, and Amitabha Mazumder. "Differential Activity of Brain Derived Neurotrophic Factor (BDNF) and RANKL in Promoting Osteoclast Activity in Multiple Myeloma Patients with or without Bone Disease." Blood 124, no. 21 (December 6, 2014): 2058. http://dx.doi.org/10.1182/blood.v124.21.2058.2058.
Full textIonescu, Filip, Nwabundo Anusim, Eva Ma, Lihua Qu, Leann Blankenship, Michael Stender, and Ishmael Jaiyesimi. "Inferior Vena Cava Filter Retrieval Trends: A Single Center Experience." Blood 134, Supplement_1 (November 13, 2019): 4690. http://dx.doi.org/10.1182/blood-2019-129366.
Full textWang, Wenrui. "The Ways that Digital Technologies Inform Visitor's Engagement with Cultural Heritage Sites: Informal Learning in the Digital Era." GATR Global Journal of Business Social Sciences Review 10, no. 4 (December 30, 2022): 237–48. http://dx.doi.org/10.35609/gjbssr.2022.10.4(3).
Full textKumar, Priya, Todd E. Defor, Claudio Brunstein, Juliet Barker, John E. Wagner, Daniel J. Weisdorf, Jeffrey S. Miller, et al. "Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Treatment of Acute Lymphocytic Leukemia (ALL) in 126 Adults: Impact of Donor Source on Leukemia Free Survival (LFS)." Blood 106, no. 11 (November 16, 2005): 2064. http://dx.doi.org/10.1182/blood.v106.11.2064.2064.
Full textMorel, J., L. Dagna, B. Joven-Ibáñez, T. Holzkaemper, C. El Baou, L. Unger, A. Semeraro, N. Gullick, and T. Treuer. "AB0899 A 24-month Prospective Psoriatic Arthritis Observational Study of Persistence of Treatment (PRO-SPIRIT) - Interim Analysis of Baseline Characteristics." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1578.1–1578. http://dx.doi.org/10.1136/annrheumdis-2022-eular.1984.
Full textDewi, Melina Surya, and Yufiarti. "Play-based Learning Activities for Creativity in Children's Dance Movements." JPUD - Jurnal Pendidikan Usia Dini 15, no. 1 (April 30, 2021): 101–20. http://dx.doi.org/10.21009/jpud.151.06.
Full textCortivo, Liliane Dal, Mathilde Bahuaud, Marie Noelle Lacassagne, Vincent Monchois, Cecile Ducasse, and Marina Cavazzana-Calvo. "Anti CMV Immunotherapy with Donor Antigen Specific Lymphocytes Selected with GMP HLA Class 1 Tetramer Reagents." Blood 114, no. 22 (November 20, 2009): 4492. http://dx.doi.org/10.1182/blood.v114.22.4492.4492.
Full textSehn, Laurie H., Angela Giovanna Congiu, Dominic J. Culligan, Mercedes Gironella, Dok Hyun Yoon, Michinori Ogura, Andras Rosta, et al. "No Added Benefit of Eight Versus Six Cycles of CHOP When Combined with Rituximab in Previously Untreated Diffuse Large B-Cell Lymphoma Patients: Results from the International Phase III GOYA Study." Blood 132, Supplement 1 (November 29, 2018): 783. http://dx.doi.org/10.1182/blood-2018-99-116845.
Full textBurns, David, Katherine Clesham, Joanna Haughton, Michelle Lannon, Hayder Hussein, Jennifer Marsh, Martin Rowe, et al. "Outcomes With Rituximab Monotherapy Versus R-CHOP In Post-Transplant Lymphoproliferative Disease Arising After Solid Organ Transplant: A Multicentre UK Study." Blood 122, no. 21 (November 15, 2013): 3043. http://dx.doi.org/10.1182/blood.v122.21.3043.3043.
Full textAbaza, Yasmin, Hagop M. Kantarjian, Gautam Borthakur, Guillermo Garcia-Manero, Naval Daver, Farhad Ravandi, Srdan Verstovsek, et al. "An Open-Label, Phase I Study of Dasatinib in Combination with Decitabine in Patients (Pts) with Accelerated or Blastic Phase Chronic Myeloid Leukemia (CML)." Blood 128, no. 22 (December 2, 2016): 5433. http://dx.doi.org/10.1182/blood.v128.22.5433.5433.
Full textPieri, Lisa, Giada Rotunno, Francesca Gesullo, Tiziana Fanelli, Giuditta Corbizi Fattori, Annalisa Pacilli, Federica Scarfì, et al. "Prognotic Impact of Mutations in Systemic Mastocytosis." Blood 128, no. 22 (December 2, 2016): 1953. http://dx.doi.org/10.1182/blood.v128.22.1953.1953.
Full textM, Luis Villela, Ana Ramirez-Ibarguen, Brady E. Beltrán, Victoria Otero, Denisse A. Castro, Myrna Candelaria, Fernando Pérez-Jacobo, et al. "Assessment of Different Biological Variables (Serum Albumin, β-2-Microglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival." Blood 134, Supplement_1 (November 13, 2019): 1613. http://dx.doi.org/10.1182/blood-2019-123841.
Full textFix, Samantha, Marie-Andrée Forget, Donastas Sakellariou-Thompson, Yunfei Wang, Ana Lucía Dominguez, Rafet Basar, Christopher Reyes, et al. "172 Overcoming immunosuppressive TGF-β signaling in human ovarian cancer-derived tumor infiltrating lymphocytes via non-viral CRISPR engineering." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A183—A184. http://dx.doi.org/10.1136/jitc-2021-sitc2021.172.
Full textCorcione, Silvia, Cecilia Grosso, Ernesta Audisio, Jessica Cusato, Miriam Antonucci, Alessandro Busca, Benedetto Bruno, Annamaria Gulla, Antonio d'Avolio, and francesco Giuseppe de Rosa. "Pharmacogenetics and Pharmacokinetics of Posaconazole in Patients with Acute Myeloid Leukemia: Useful Tools for Antifungal Stewardship." Blood 142, Supplement 1 (November 28, 2023): 5849. http://dx.doi.org/10.1182/blood-2023-190034.
Full textBishton, Mark, Pier Luigi Zinzani, Scott Marshall, Veronica Conteh, Alicia Rodríguez Fernández, SooKyoung Kim, and Young Nam Lee. "Rapid Infusion with CT-P10 in Patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukaemia: Interim Six Month Follow-up from a European Non-Interventional Post-Authorisation Safety Study." Blood 134, Supplement_1 (November 13, 2019): 4135. http://dx.doi.org/10.1182/blood-2019-121957.
Full textNovi Sekar Sari, Ririn Tri Ratnasari, Ismah Osman, and Ega Rusanti. "Materialism and Environmental Knowledge as a Mediator for Relationships between Religiosity and Ethical Consumption." Jurnal Ekonomi Syariah Teori dan Terapan 10, no. 5 (September 30, 2023): 467–81. http://dx.doi.org/10.20473/vol10iss20235pp467-481.
Full textMacMillan, Margaret L., Marie Robin, Andrew C. Harris, Todd E. Defor, Paul J. Martin, Amin Alousi, Vincent T. Ho, et al. "A Refined Clinical Risk Score at Onset of Treatment for Acute Gvhd That Predicts Response to Initial Therapy, Survival and Transplant-Related Mortality." Blood 124, no. 21 (December 6, 2014): 188. http://dx.doi.org/10.1182/blood.v124.21.188.188.
Full textWang, Michael, Javier Munoz, Andre H. Goy, Frederick L. Locke, Caron A. Jacobson, Brian T. Hill, John M. Timmerman, et al. "One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients with Relapsed/Refractory Mantle Cell Lymphoma." Blood 136, Supplement 1 (November 5, 2020): 20–22. http://dx.doi.org/10.1182/blood-2020-136382.
Full textWarmansyah, Jhoni, Elis Komalasari, Eliza Febriani, Gusmiati, and Amalina. "Factors Affecting Teacher Readiness for Online Learning (TROL) in Early Childhood Education: TISE and TPACK." JPUD - Jurnal Pendidikan Usia Dini 16, no. 1 (April 30, 2022): 32–51. http://dx.doi.org/10.21009/jpud.161.03.
Full textKohls-Santos, Pricila, and Marília Costa Morosini. "Trilha para internacionalização em casa: Brasil-Colômbia em espaços não formais (Trail to internationalization at home: Brazil-Colombia in non-formal spaces)." Revista Eletrônica de Educação 15 (November 30, 2021): e4884048. http://dx.doi.org/10.14244/198271994884.
Full textImber, Brandon S., Miguel-Angel Perales, Jessica Flynn, Josel D. Ruiz, Sean Devlin, Ana Alarcon Tomas, Carla Hajj, et al. "Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas." Blood 136, Supplement 1 (November 5, 2020): 1–2. http://dx.doi.org/10.1182/blood-2020-140991.
Full text